Q32 Bio

1 follower

‌

Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Jodie Morrison

Acting CEO

Jodie Morrison

Collapse

Shelia Violette

Co-Founder & Chief Scientific Officer

Jason Campagna

Chief Medical Officer

David Appugliese

SVP & Head of People

Maria Marzilli

EVP, Corporate Strategy & Program Operations

Bill Lundberg

Independent Director

Dessi McEntee, MS, DABT

Associate Director, Toxicology

Fei Liu

Director, Pharmacology

Hong Wu, MD, PhD, DABT

Vp, Head Of Translational, Clinical Pharm, & Nonclinical Dev

Isidora Tošić

New Product Planning Manager

Joel Scherer

Vice President, Clinical Development, Immunotherapeutics

Justin Rogers

Director, Quality Assurance

Reena Malik

Associate Director - Regulatory Affairs

Theresa Carbeau

Director, CMC

Eric Bell

Senior Vice President Finance And Controller

Teams

+10

Finance & Strategic Planning

13 members

+10

Scientific Research & Development

13 members

Leadership Team

5 members

Clinical Operations

4 members

Quality Assurance & Regulatory Affairs

3 members

Similar companies

Immunome

2 followers

Elicio Therapeutics

1 follower

Nunzio Marc DeSantis Architects

1 follower

Artiva Biotherapeutics

1 follower

Lucid Management and Capital Partners LP

1 follower

Amgen

208 followers

Capricor Therapeutics

1 follower

Merkle

63 followers

Medidata Solutions

25 followers

15 followers

Cytokinetics

11 followers

Explore companies